BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 2:46:00 PM | Browse: 559 | Download: 541
|
Received |
|
2013-11-20 12:08 |
|
Peer-Review Started |
|
2013-11-21 17:59 |
|
To Make the First Decision |
|
2013-12-16 17:14 |
|
Return for Revision |
|
2013-12-17 14:12 |
|
Revised |
|
|
|
Second Decision |
|
2014-03-06 17:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-03-06 18:19 |
|
Articles in Press |
|
2014-05-23 09:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-06-05 11:16 |
|
Publish the Manuscript Online |
|
2014-06-21 13:56 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Nanotechnology applications for the therapy of liver fibrosis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Lydia Giannitrapani, Maurizio Soresi, Maria Luisa Bondì, Giuseppe Montalto and Melchiorre Cervello |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Italian Ministero dell’Istruzione, dell’Università e della Ricerca (Ministry for Education, Universities and Research), MIUR FIRB-MERIT |
RBNE08YYBM (to Cervello M) |
Italian Ministero dell’Istruzione, dell’Università e della Ricerca (Ministry for Education, Universities and Research), MIUR FIRB-MERIT |
RBNE08YYBM (to Montalto G) |
Italian Ministero dell’Istruzione, dell’Università e della Ricerca (Ministry for Education, Universities and Research), MIUR FIRB-MERIT |
RBNE08YYBM (to Bondì ML) |
|
Corresponding Author |
Lydia Giannitrapani, MD, PhD, Unit of Internal Medicine, Biomedical Department of Internal Medicine and Specialties DiBiMIS, University of Palermo, Via del Vespro 141, 90127 Palermo, Italy. lydiagiannitp@gmail.com |
Key Words |
Liver fibrosis; Nanotechnology; Nanoparticles; Hepatic stellate cells; Antifibrotic drugs; Cirrhosis |
Core Tip |
New drugs or new drug delivery strategies to cure liver fibrosis are needed to find effective therapeutic options for this pathologic condition. Therapies based on nanotechnologies have emerged as an innovative and promising alternative to conventional therapies. This work aims to review the most recent literature about the use of nanotechnology approaches to reduce liver fibrosis. |
Publish Date |
2014-06-21 13:56 |
Citation |
Giannitrapani L, Soresi M, Bondì ML, Montalto G, Cervello M. Nanotechnology applications for the therapy of liver fibrosis. World J Gastroenterol 2014; 20(23): 7242-7251 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i23/7242.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i23.7242 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345